BDO has co-advised Astorg on their acquisition of a majority stake in Avania.
Avania is a leading global, full-service contract research organisation concentrating on the management of clinical studies for medical technology, IVDs, biologics, and device-drug combination products. Avania's medical technology offerings cover the full regulatory lifecycle across a broad range of therapeutic areas.
Due to its uniquely structured solutions and differentiated propositioning, Avania has experienced strong organic growth and has become a trusted global partner in the evolution of medical technology. Astorg’s investment will enable Avania to continue to expand its service offering and geographical reach.